Debjit Chattopadhyay
Stock Analyst at Guggenheim
(4.53)
# 262
Out of 5,055 analysts
108
Total ratings
59.18%
Success rate
19.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Maintains: Buy | $22 → $19 | $18.81 | +1.01% | 7 | Nov 5, 2025 | |
| LXEO Lexeo Therapeutics | Initiates: Buy | $30 | $9.04 | +231.86% | 1 | Oct 15, 2025 | |
| CNTA Centessa Pharmaceuticals | Reiterates: Buy | $28 | $27.61 | +1.41% | 7 | Oct 6, 2025 | |
| QURE uniQure | Maintains: Buy | $28 → $95 | $29.88 | +217.94% | 7 | Sep 25, 2025 | |
| PEPG PepGen | Reiterates: Buy | $6 | $4.74 | +26.58% | 2 | Sep 24, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $90 → $92 | $71.55 | +28.58% | 6 | Sep 23, 2025 | |
| RZLT Rezolute | Reiterates: Buy | $15 | $9.87 | +51.98% | 3 | Sep 22, 2025 | |
| MAZE Maze Therapeutics | Maintains: Buy | $19 → $34 | $32.52 | +4.55% | 3 | Sep 15, 2025 | |
| SLNO Soleno Therapeutics | Reiterates: Buy | $106 | $49.42 | +114.49% | 5 | Aug 27, 2025 | |
| PASG Passage Bio | Maintains: Buy | $40 → $10 | $8.85 | +12.99% | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $14 | $8.70 | +60.92% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $106 | $54.73 | +93.68% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $558 → $546 | $437.15 | +24.90% | 8 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $64 | $33.08 | +93.47% | 3 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $18.79 | +166.10% | 5 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $189 | $206.16 | -8.32% | 4 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $55 | $21.72 | +153.22% | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $3.37 | +434.12% | 3 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $13.16 | +29.18% | 2 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $9.49 | +58.14% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Neutral | n/a | $52.53 | - | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $5.88 | +223.13% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $3.94 | +459.09% | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $38.35 | -21.77% | 1 | Jan 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $29 | $1.23 | +2,257.72% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $449.16 | - | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $4.13 | +577.97% | 1 | Dec 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $20 | $7.08 | +182.49% | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $270 → $123 | $31.31 | +292.85% | 8 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $54 | $18.52 | +191.58% | 3 | Jul 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $60 | $1.25 | +4,700.00% | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $43.65 | - | 3 | Jun 26, 2017 |
Sarepta Therapeutics
Nov 5, 2025
Maintains: Buy
Price Target: $22 → $19
Current: $18.81
Upside: +1.01%
Lexeo Therapeutics
Oct 15, 2025
Initiates: Buy
Price Target: $30
Current: $9.04
Upside: +231.86%
Centessa Pharmaceuticals
Oct 6, 2025
Reiterates: Buy
Price Target: $28
Current: $27.61
Upside: +1.41%
uniQure
Sep 25, 2025
Maintains: Buy
Price Target: $28 → $95
Current: $29.88
Upside: +217.94%
PepGen
Sep 24, 2025
Reiterates: Buy
Price Target: $6
Current: $4.74
Upside: +26.58%
Ionis Pharmaceuticals
Sep 23, 2025
Maintains: Buy
Price Target: $90 → $92
Current: $71.55
Upside: +28.58%
Rezolute
Sep 22, 2025
Reiterates: Buy
Price Target: $15
Current: $9.87
Upside: +51.98%
Maze Therapeutics
Sep 15, 2025
Maintains: Buy
Price Target: $19 → $34
Current: $32.52
Upside: +4.55%
Soleno Therapeutics
Aug 27, 2025
Reiterates: Buy
Price Target: $106
Current: $49.42
Upside: +114.49%
Passage Bio
Aug 14, 2025
Maintains: Buy
Price Target: $40 → $10
Current: $8.85
Upside: +12.99%
Aug 13, 2025
Maintains: Buy
Price Target: $45 → $14
Current: $8.70
Upside: +60.92%
Aug 6, 2025
Maintains: Buy
Price Target: $101 → $106
Current: $54.73
Upside: +93.68%
Aug 6, 2025
Maintains: Buy
Price Target: $558 → $546
Current: $437.15
Upside: +24.90%
Jun 20, 2025
Reiterates: Buy
Price Target: $64
Current: $33.08
Upside: +93.47%
Jun 18, 2025
Reiterates: Buy
Price Target: $50
Current: $18.79
Upside: +166.10%
May 7, 2025
Maintains: Buy
Price Target: $195 → $189
Current: $206.16
Upside: -8.32%
May 7, 2025
Maintains: Buy
Price Target: $78 → $55
Current: $21.72
Upside: +153.22%
Dec 3, 2024
Reiterates: Buy
Price Target: $18
Current: $3.37
Upside: +434.12%
Dec 3, 2024
Reiterates: Buy
Price Target: $17
Current: $13.16
Upside: +29.18%
Nov 7, 2024
Maintains: Buy
Price Target: $13 → $15
Current: $9.49
Upside: +58.14%
Jun 28, 2024
Assumes: Neutral
Price Target: n/a
Current: $52.53
Upside: -
Apr 30, 2024
Initiates: Buy
Price Target: $19
Current: $5.88
Upside: +223.13%
Mar 26, 2024
Initiates: Buy
Price Target: $22
Current: $3.94
Upside: +459.09%
Jan 18, 2024
Initiates: Buy
Price Target: $30
Current: $38.35
Upside: -21.77%
Nov 21, 2022
Maintains: Buy
Price Target: $43 → $29
Current: $1.23
Upside: +2,257.72%
Jun 27, 2022
Downgrades: Neutral
Price Target: n/a
Current: $449.16
Upside: -
Dec 16, 2021
Initiates: Buy
Price Target: $28
Current: $4.13
Upside: +577.97%
Dec 15, 2020
Assumes: Buy
Price Target: $20
Current: $7.08
Upside: +182.49%
Aug 24, 2020
Downgrades: Neutral
Price Target: $270 → $123
Current: $31.31
Upside: +292.85%
Jul 9, 2020
Maintains: Buy
Price Target: $60 → $54
Current: $18.52
Upside: +191.58%
Dec 3, 2019
Downgrades: Neutral
Price Target: $60
Current: $1.25
Upside: +4,700.00%
Jun 26, 2017
Downgrades: Neutral
Price Target: n/a
Current: $43.65
Upside: -